Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-25 @ 1:37 PM
NCT ID: NCT04976192
Term: Injection site induration
Organ System: General disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 24.0
Notes: None
Study: NCT04976192
Study Brief: Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 17 12 201 View
EG001 6 6 102 View
EG002 15 12 203 View
EG003 7 5 102 View
EG004 15 7 188 View
EG005 4 3 98 View
EG006 4 3 97 View
EG007 1 1 51 View
EG008 5 3 97 View
EG009 9 3 50 View